£203.99

Myelodysplastic Syndrome: From Diagnosis to Treatment (Recent Advances in Hematology Research)

Internal Medicine

Price data last checked 69 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£204 today · previous high £204 · all-time low £153

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 22 days • 22 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 22 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £153 (21 days, 95.5%)

Price range: £153 - £204

Price levels: 2 different prices over 22 days

Description

In this compilation, the authors review the biological aspects of myelodysplastic syndrome disease, diagnosis, and treatment, as well as innovations involving genetics and new treatment perspectives. Myelodysplastic syndromes are a heterogeneous group of clonal haematopoietic stem cells disorders characterized by dysplasia, as well as peripheral blood cytopenias with a hypercellular marrow and ineffective hematopoiesis. Myelodysplastic syndromes are frequently associated with acute and chronic inflammation, and autoimmune disorders such as: rheumatoid arthritis, bowel disease, diverse types of vasculitis, autoimmune anemias, several rheumatic and skin disorders, and certain thyroid disorders. Spliceosome mutations are the most frequent mutations found in blood and bone marrow cells of myelodysplastic syndromes patients. As such, the authors explore the four predominant splicing factor genes: SF3B1, SFRS2, U2AF1, ZRSR2. Subsequently, this collection discusses the CSNK1A1 gene in the context of myelodysplastic syndromes. It is located at 5q32 within the deleted region, which encodes for casein kinase 1α (CK1α). CK1α is a component of a multiprotein β-catenin destruction complex that regulates Wnt/β-catenin and p53 pathways. The concluding study focuses on the mutations in epigenetic modifiers occur which myelodysplastic syndromes and drive this disease, such as: DNA methylation, histone acetylation, and RNA interference that alters gene expression.

Product Specifications

Format: hardcover
ASIN: 1536179973
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine
Domain: Amazon UK
Release Date: 22 July 2020
Listed Since: 09 June 2020

Barcode

No barcode data available

Myelodysplastic Syndrome: From Diagnosis to Treatment (Recent Advances in Hematology Research)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Myeloproliferative Disorders: Symptoms, Risk Factors and Treatment Options (Recent Advances in Hematology Research)

Myeloproliferative Neoplasms, An Issue of Hematology/Oncology Clinics of North America: Volume 35-2 (The Clinics: Internal Medicine, Volume 35-2)

Springer - Chronic Myeloid Neoplasias and Clonal Overlap Syndromes

Springer - The Myelodysplastic Syndromes Medical Text

Hematopoiesis - Biochemical, Cellular, and Genomic Perspectives

Bone Marrow Failure, An Issue of Hematology/Oncology Clinics of North America (Volume 32-4) (The Clinics: Internal Medicine, Volume 32-4)

Myelodysplastic Syndromes: Pathobiology and Clinical Management: 36 (Basic and Clinical Oncology)

Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America: Volume 35-4 (The Clinics: Internal Medicine, Volume 35-4)

Myelodysplastic Syndromes, An Issue of Hematology/Oncology Clinics of North America (Volume 34-2) (The Clinics: Internal Medicine, Volume 34-2)

Bone Marrow Failure (Pediatric Oncology)

Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia

Contemporary Management of Myeloproliferative Neoplasms

Normal and Malignant Hematopoieses: New Advances - Proceedings of the Sixth Pezcoller Symposium Held in Rovereto, Italy, June 29-July 1, 1994: v. 6

Preleukemia

Diagnostic Pathology: Blood and Bone Marrow

Myeloproliferative Neoplasms: Biology and Therapy (Contemporary Hematology)

Molecular Hematology

Manual of Hematopoietic Cell Transplantation and Cellular Therapies

Acute Myeloid Leukemia (Hematologic Malignancies)

American Registry of Pathology Non-Neoplastic Bone Marrow Atlas

Humana Myeloproliferative Neoplasms: Biology and Therapy

Colony-Stimulating Factors: Molecular & Cellular Biology, Second Edition,

Chronic Myeloid Leukemia: Methods and Protocols: 1465 (Methods in Molecular Biology)

Managing Myeloproliferative Neoplasms: A Case-Based Approach